{
  "docId": "019dd923-5e88-73ef-bd5a-c8877c2d773b",
  "docSlug": "62a053437732d31d",
  "documentTitle": "250114 FRE prsn JPM SFO 0",
  "authorId": "JPMorgan",
  "authorName": "Fresenius",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "equity_research",
  "sourceTypeLabel": "Equity research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 12,
  "pageCount": 15,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "kpi_dashboard",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 8,
  "notes": "The slide uses a 'before-after' comparison structure to highlight financial improvement.",
  "elementsJson": [
    "headline_text",
    "kpi_table",
    "icon_grid"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5a-c8877c2d773b/12",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5a-c8877c2d773b",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5a-c8877c2d773b.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-c8877c2d773b#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.92,
        "x": 0.04,
        "y": 0.9
      },
      "kind": "disclaimer",
      "text": "Revenue, EBIT & EPS: Before special items; at constant currency; growth rates adjusted for Argentina hyperinflation | FY 2022 figures incl. FMC & Vamed | 1 Net income attributable to shareholders of Fresenius SE & Co. KGaA | 2 Excluding FMC result (at equity) | 3 Excl. FMC; at average exchange rates for both net debt and EBITDA; before special items; pro forma closed acquisitions/divestitures, including lease liabilities, including Fresenius Medical Care dividend",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "37779843-a532-41f7-8cf6-d0ca6e016513",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Revenue growth: +8%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-28a9-71be-806d-ca0dd9798a4d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.92,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "table",
      "text": "Revenue growth, EBIT margin, Earnings per share, Leverage",
      "attrs": null,
      "subkind": "kpi",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "366aa620-06a5-40c6-a175-af3125ec1ebf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.04,
        "y": 0.1
      },
      "kind": "title",
      "text": "Significant financial progression based on new setup",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "adf52114-4e37-49d2-a54e-e8b9e97941ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "#Future Fresenius",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "504db15f-2b53-463e-9b50-af8fcac44c9a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "5c47da09-93de-4f3a-916f-84fa6b643692",
      "evidence": "Compares FY 2022/Q4 2023 metrics against Q1-3 2024/Q3 2024 to show improvement.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 12,
      "from": 8,
      "beatId": "96ffe88c-8d2a-4d23-a98c-19240d899804",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "Slides 8-12 provide data and metrics on Fresenius Kabi's momentum, growth, and financial progression.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}